Radiotherapy News and Research

RSS

Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).

Radiotherapy may cause low-grade intestinal inflammation in cancer survivors

Patients who have undergone pelvic radiotherapy may live with low-grade chronic inflammation of the lower intestine 20 years after the treatment. 0

29 Sep 2023

The fight against cancer: a comprehensive assessment of preventable and treatable cases

Researchers presented the findings of a population-based study conducted across 185 countries to estimate premature deaths due to 36 different types of cancers in 2020, a leading cause of premature deaths worldwide.

29 Sep 2023

Study details the key role played by neutrophils in ensuring survival of brain cancers

A Ludwig Cancer Research study has for the first time exhaustively analyzed immune cells known as neutrophils that reside in brain tumors, including gliomas, which develop in the brain itself, and cancers that spread there from the lung, breast and skin.

27 Sep 2023

AI model accurately forecasts patient outcomes for common lung cancer after surgery

Researchers develop an AI model to accurately predict prognosis for patients with non-small cell lung cancer after surgery. The model, which utilized a range of preoperative and postoperative blood test results, achieved high prediction accuracy, offering a promising approach for personalized treatment plans.

25 Sep 2023

Unlocking the power of mRNA vaccines: From COVID-19 to cancer and beyond

A comprehensive review in Signal Transduction and Targeted Therapy delves into the versatility and effectiveness of mRNA vaccines, from their game-changing role in COVID-19 to potential applications in cancer and rare diseases. Despite drawbacks like stability and high immunogenicity, advancements in vaccine technology have poised mRNA platforms as a robust tool for both preventive and therapeutic interventions.

21 Sep 2023

Intensity-modulated radiation therapy reduces radiation exposure to heart and lungs in NSCLC patients

Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the heart and lungs, according to researchers at The University of Texas MD Anderson Cancer Center.

12 Sep 2023

Childhood cancer treatment linked to higher breast cancer risk

Women who have been treated for cancer as a child with a certain type of chemotherapy have an increased risk of breast cancer, according to a large-scale international study of survivors of childhood cancer led by scientists from the Princess Máxima Center for pediatric oncology.

11 Sep 2023

Researchers uncover evidence supporting shorter-course proton therapy for breast cancer patients

In a randomized trial, published in The Lancet Oncology, Mayo Clinic Comprehensive Cancer Center researchers uncover evidence supporting a shorter treatment time for breast cancer patients.

8 Sep 2023

Elekta and the International Atomic Energy Agency (IAEA) partner to improve access to cancer care in underserved countries

Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden

From Elekta 8 Sep 2023

Silencing two genes can make cancer cells receptive to chemotherapy

Scientists from Queen Mary University of London have discovered two new genes that cause head and neck cancer patients to be resistant to chemotherapy, and that silencing either gene can make cancer cells previously unresponsive to chemotherapy subsequently respond to it.

4 Sep 2023

New breakthroughs by NPL scientists could transform cancer treatment

New breakthroughs by scientists at the National Physical Laboratory (NPL) are set to transform cancer treatment in the UK and worldwide.

4 Sep 2023

Study challenges the use of biochemical recurrence as prostate cancer predictor

A UCLA-led study found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising prostate-specific antigen (PSA) levels after radiotherapy, commonly referred to as biochemical recurrence, do not necessarily improve a patient's long-term overall survival.

28 Aug 2023

Radiotherapy News and Research

Further Reading

Radiotherapy may cause low-grade intestinal inflammation in cancer survivors

The fight against cancer: a comprehensive assessment of preventable and treatable cases

Study details the key role played by neutrophils in ensuring survival of brain cancers

AI model accurately forecasts patient outcomes for common lung cancer after surgery

Unlocking the power of mRNA vaccines: From COVID-19 to cancer and beyond

Intensity-modulated radiation therapy reduces radiation exposure to heart and lungs in NSCLC patients

Childhood cancer treatment linked to higher breast cancer risk

Researchers uncover evidence supporting shorter-course proton therapy for breast cancer patients

Elekta and the International Atomic Energy Agency (IAEA) partner to improve access to cancer care in underserved countries

Silencing two genes can make cancer cells receptive to chemotherapy

New breakthroughs by NPL scientists could transform cancer treatment

Study challenges the use of biochemical recurrence as prostate cancer predictor

Study shows not all adrenal carcinoma patients need mitotane after surgery

Newly published ESC Guidelines provide comprehensive overview of acute coronary syndromes

Less is more: Radiotherapy omission deemed safe for certain breast cancer patients

MedAustron demonstrates safety and efficacy of ion therapy for treating skull based chordomas

Some early-stage, low-risk breast cancer patients may not need radiotherapy after surgery

Androgen deprivation therapy increases the risk of depression, dementia, Alzheimer’s disease, and Parkinson’s disease

Proton radiotherapy used for the first time in Switzerland to treat esophageal tumor

Early lung cancer detection with a machine learning model based on imaging, clinical, and DNA methylation biomarkers

Cancer Research - Second Edition eBook

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News